Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase (IC50s: 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
2 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 448.00 | |
10 mg | In stock | $ 658.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,380.00 | |
100 mg | In stock | $ 1,890.00 | |
500 mg | In stock | $ 3,780.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 587.00 |
Description | CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase (IC50s: 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein). |
Targets&IC50 | Abl (WT):2 nM, Abl (T315I):0.2 nM |
In vitro | CHMFL-ABL-121 induces apoptosis and arrests the cell cycle at the G0/G1 phase. CHMFL-ABL-121 dose-dependently inhibits BCRABL's auto-phosphorylation at the Y245 site in MEG-01 (EC50<10 nM), K562 (EC50<10 nM), and KU812 (EC50<30 nM) cells and also significantly blocks the phosphorylation of downstream signaling mediators STAT5, CrkL, and ErK[1]. |
Molecular Weight | 580.67 |
Formula | C30H31F3N6OS |
CAS No. | 2270879-07-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (94.72 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CHMFL-ABL-121 2270879-07-5 Angiogenesis Cytoskeletal Signaling Tyrosine Kinase/Adaptors Bcr-Abl CHMFL-ABL121 CHMFL-ABL 121 CHMFLABL121 CHMFL ABL 121 inhibitor inhibit